WallStSmart
MASI

Masimo Corporation

NASDAQ: MASI · HEALTHCARE · MEDICAL DEVICES

$178.46
-0.03% today

Updated 2026-04-29

Market cap
$9.34B
P/E ratio
46.47
P/S ratio
6.12x
EPS (TTM)
$3.84
Dividend yield
52W range
$126 – $179
Volume
1.6M

Masimo Corporation (MASI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+5.1%
Last 4 quarters
Revenue YoY growth
-31.3%
Most recent quarter
EPS YoY growth
-27.2%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.0%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-10.3%
2025-08-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-26$1.31-10.8%$175.10$175.35+0.1%
2025-11-04$1.32+10.0%$144.96$142.14-1.9%
2025-08-05$1.33+9.0%$161.27$144.65-10.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$1.47$1.31-10.8%$412.50M-31.3%
2025-09-30$1.20$1.32+10.0%$371.50M-26.4%
2025-06-30$1.22$1.33+9.0%$370.90M+7.9%
2025-03-31$1.21$1.36+12.4%$372.00M+9.5%
2024-12-31$1.42$1.80+26.8%$600.70M+9.4%
2024-09-30$0.84$0.86+2.4%$504.60M+5.4%
2024-06-30$0.76$0.86+13.2%$343.90M-24.5%
2024-03-31$0.69$0.66-4.3%$339.60M
2023-12-31$0.88$1.06+20.5%$548.90M
2023-09-30$0.59$0.63+6.8%$478.90M
2023-06-30$0.56$0.62+10.7%$455.30M

Frequently asked questions

Has Masimo Corporation beaten earnings estimates?
Masimo Corporation has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +5.1% over the last 4 quarters.
How does MASI stock react to earnings?
MASI stock has moved an average of -4.0% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Masimo Corporation's revenue growth rate?
Masimo Corporation reported year-over-year revenue growth of -31.3% in its most recent quarter, with EPS growing -27.2% year-over-year.